Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...

There are about 20 million Americans living with thyroid disease, but researchers believe as many as 60% of them do not know ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, when a causative role of the drug is implausible, suggested stepped-up ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

In this issue of The Lancet Diabetes & Endocrinology, Michelle M Chen and colleagues1 report their findings on trends in the incidence of thyroid cancer in the USA from 1975 to 2019. The authors show ...

Researchers investigate the risk of incident thyroid cancer among patients treated with glucagon-like peptide-1 receptor ...

Thyroid cancer is classified based on the types of cells found in the tumor. Most thyroid cancers are slow-growing, and some can be aggressive and according to Dr. Chery, the most common types of ...

Patients with type 2 diabetes who had initiated GLP-1 RAs were identified and compared with those initiating dipeptidyl peptidase 4 inhibitors ... in the risk for thyroid cancer was observed ...